跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Trilaciclib Hydrochloride for Injection
Approved
化学药品
Trilaciclib Hydrochloride for Injection
G1 Therapeutics
🇨🇳 National Medical Products Administration
Approval Date
Jul 12, 2022
Approval ID
8Hqqsls8bGm
Company
G1 Therapeutics
Type
化学药品
Approval Details
Approval Id
8Hqqsls8bGm
Approval Number
国药准字HJ20220066
Generic Name
注射用盐酸曲拉西利
Generic Name En
Trilaciclib Hydrochloride for Injection
Trade Name
科赛拉
Drug Type
化学药品
Dosage Form
注射剂
Strength
300mg(按C₂₄H₃₀N₈O计)
Reg Date
2022-07-12
Expired Date
2027-07-11
Company Name
G1 Therapeutics
Production Company Name
Patheon Manufacturing Services LLC
Company Detail Path
/organization/g1-therapeutics
Production Company Detail Path
/organization/patheon-manufacturing-services-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 12, 2022
Approval ID
8Hqqsls8bGm
Type
化学药品
Back to NMPA Approvals
科赛拉 - NMPA Drug Approval Details